维普期刊资源整合服务平台（V6.5）

86篇 您的检索式：作者名="APPERLEY JF"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelct-derived growth factor receptor beta显示文摘	Apperley JF Gardembas M Mela JV	2002	N Engl J Med2002，347，7：	1
2	Response to imatinibmesylate in patients with chronic myeloproliferative diseases withrearrangements of the platelet-derived growth factor receptor be-ta显示文摘	Apperley JF Gardembas M Melo JV	2002	N Engl J Med2002，347，：	1
3	Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
4	Chronic myelogenous leukemia显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology2003，，：	1
5	How I treat leukemia dur- ing pregnaney显示文摘	Milojkovic D Apperley JF	2014	Blood2014，123，：	1
6	HLAB8and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of development of chronic myeloid leukemia显示文摘	Posthuma EF Falkenburg JH Apperley JF	1999	Blood1999，93，：	1
7	Poor adherence is the main reason for loss of CCyR and imatinib failure for chron- ic myeloid leukemia patients on long-term therapy 显示文摘	Ibrahim AR Eliasson L Apperley JF	2011	Blood2011，117，14：	1
8	HLA-DR4 ia associated with a diminished risk of the development of chronic myeloid leukemia (CML)显示文摘	Posthuma EFM Falkenburg JHF Apperley JF	2000	Leukemia2000，14，：	1
9	Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia显示文摘	WADHWA J SZYDLO RM APPERLEY JF	2002	Blood2002，99，7：	1
10	Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib 显示文摘	Cheah CY Burbury K Apperley JF	2014	Blood2014，123，23：	1
11	Part I:Meehanisms of Resistance to Imatinib in Chronic Myeloid Leukaemia显示文摘	Apperley JF	2007	Lancet Oncol2007，8，11：	1
12	Soluble re-ceptor activator of nuclear factor kB ligand-osteo-protegerin ratio predicts survival in multiple myelo-ma :proposal for a novel prognostic index 显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
13	Chronic Myeloid Leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology Am Soc Hematol Educ Program2003，2003，1：	1
14	Chronic myeloid leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematol Am Soc Hematol Educ Program2003，，1：	1
15	Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis显示文摘	de Lavallade H Apperley JF Khorashad JS	2008	J Clin Oneol2008，26，20：	1
16	Chronic myeloid leukemia显示文摘	Apperley JF	2015	Lancet2015，385，9976：	1
17	Poor adherence isthe main reason for loss of CCyR and imatinib failure for chronicmyeloid leukemia patients on long-term therapy 显示文摘	Ibrahim AR Eliasson L Apperley JF	2011	Blood2011，117，14：	1
18	:Dasatinib in the treatmentof chronic myeloid leukemia in accelerated phase after imatinib fail-ure:the START a trial显示文摘	Apperley JF Cortes JE Kim DW	2009	J Clin Oncol2009，27，34：	1
19	Amuhicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft- versus-host disease 显示文摘	Flowers ME Apperley JF van Besien K	2008	Blood2008，112，7：	1
20	HLA2B8 and HLA2A3 coexp ressed with HLA2B8 are associated with a reduced risk of the development of chronic myeloid leukemia 显示文摘	Posthuma EF Falkenburg JH Apperley JF	1999	Blood1999，93，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示